Joan García‐López

1.4k citations

20 papers · 1.1k indexed · 1 hit paper · h-index 14

Co-authors: ID Bernstein RJ Berenson Jack W. Singer RG Andrews R.S. Hill Gary Spitzer CD Buckner Jordi Pétriz
Topics: Mesenchymal stem cell research (10 papers)Hematopoietic Stem Cell Transplantation (7 papers)Cancer Cells and Metastasis (3 papers)
Cited by: Hematology Genetics Urology
Journals: SHILAP Revista de lepidopterologíaBlood The Lancet Oncology
Partner nations: Spain United States Germany

In The Last Decade

Joan García‐López

20 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma

1991 455 citations RJ Berenson, Jack W. Singer et al. Blood profile →

Peers

Countries citing papers authored by Joan García‐López

Since Specialization

Citations

This map shows the geographic impact of Joan García‐López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan García‐López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan García‐López more than expected).

Fields of papers citing papers by Joan García‐López

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan García‐López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan García‐López. The network helps show where Joan García‐López may publish in the future.

Co-authorship network of co-authors of Joan García‐López

This figure shows the co-authorship network connecting the top 25 collaborators of Joan García‐López. A scholar is included among the top collaborators of Joan García‐López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan García‐López. Joan García‐López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment of non-hypertrophic pseudoarthrosis of long bones with a Tissue Engineered Product loaded with autologous bone marrow-derived Mesenchymal Stromal Cells: Results from a phase IIa, prospective, randomized, parallel, pilot clinical trial comparing to iliac crest autograft 2024 ·Injury ·(unknown),(unknown),(unknown),Luciano Rodrı́guez,Margarita Codinach,Joan García‐López,(unknown),Ruth Coll,Joaquim Vives,(unknown)	3
2	Analysis of Key Indicators of Research, Development, and Innovation in Blood Establishments and Their Impact on the Delivery of Improved Quality Health Products and Services 2023 ·SHILAP Revista de lepidopterología ·(unknown),Joan García‐López,Joaquim Vives	2
3	Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance 2022 ·Cells ·Joaquim Vives,Joaquim Hernández,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Hatice Kumru,Joan García‐López,Joan Vidal,Xavier Navarro,Ruth Coll	1
4	Randomized clinical trial: expanded autologous bone marrow mesenchymal cells combined with allogeneic bone tissue, compared with autologous iliac crest graft in lumbar fusion surgery 2020 ·The Spine Journal ·(unknown),(unknown),Ruth Coll,(unknown),(unknown),(unknown),Miquel Adrover,(unknown),(unknown),(unknown),Joan García‐López,Joaquim Vives,Margarita Codinach,Luciano Rodrı́guez,Joan Bagó,(unknown)	30
5	Evaluation of a cell-based osteogenic formulation compliant with good manufacturing practice for use in tissue engineering 2020 ·Molecular Biology Reports ·(unknown),(unknown),Irene Oliver‐Vila,Joan García‐López,Joaquim Vives	6
6	Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly 2019 ·Cells ·(unknown),Luciano Rodrı́guez,(unknown),(unknown),(unknown),Margarita Codinach,Susana Gómez,Sergi Querol,Joan García‐López,Joaquim Vives	27
7	Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow–derived multipotent mesenchymal stromal cell expansion cultures 2018 ·Cytotherapy ·(unknown),Luciano Rodrı́guez,(unknown),David Vivas,Margarita Codinach,(unknown),Irene Oliver‐Vila,Joan García‐López,Joaquim Vives	20
8	Assessment of biodistribution using mesenchymal stromal cells: Algorithm for study design and challenges in detection methodologies 2017 ·Cytotherapy ·(unknown),(unknown),Margarita Codinach,(unknown),(unknown),(unknown),Irene Oliver‐Vila,Valentín Cabañas,Silvia Lope‐Piedrafita,Joan García‐López,José M. Moraleda,César G. Fontecha,Joaquim Vives	15
9	Final results of a phase I–II trial using ex vivo expanded autologous Mesenchymal Stromal Cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration 2016 ·The Knee ·Robert Soler,Lluís Orozco,(unknown),Marina Huguet,Ramon Lopez Perez,Joaquim Vives,Ruth Coll,Margarita Codinach,Joan García‐López	138
10	Qualification of Computerized Monitoring Systems in a Cell Therapy Facility Compliant with the Good Manufacturing Practices 2016 ·Regenerative Medicine ·(unknown),(unknown),(unknown),(unknown),Joan García‐López,Irene Oliver‐Vila,Joaquim Vives	2
11	Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow–derived multipotent mesenchymal stromal cells 2016 ·Cytotherapy ·Margarita Codinach,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Irene Oliver‐Vila,(unknown),Joaquim Vives,Joan García‐López	43
12	Clinical translation of a mesenchymal stromal cell-based therapy developed in a large animal model and two case studies of the treatment of atrophic pseudoarthrosis 2016 ·Journal of Tissue Engineering and Regenerative Medicine ·(unknown),(unknown),(unknown),Ana Carreño,(unknown),Irene Oliver‐Vila,(unknown),(unknown),Margarita Codinach,Pere Huguet,José Ramírez,(unknown),M Aguirre,Ruth Coll,Joan García‐López,(unknown),Joaquim Vives	14
13	Effect of donor–recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis 2011 ·The Lancet Oncology ·Mary Eapen,John P. Klein,Guillermo Sanz,Stephen R. Spellman,Annalisa Ruggeri,Claudio Anasetti,Maria Brown,Richard E. Champlin,Joan García‐López,(unknown),Gesine Koegler,Mary J. Laughlin,Gérard Michel,Samir Nabhan,Franklin O. Smith,Mary M. Horowitz,Éliane Gluckman,Vanderson Rocha	134
14	Is Rhodamine 123 an Appropriate Fluorescent Probe to Assess P‐Glycoprotein Mediated Multidrug Resistance in Vinblastine‐Resistant CHO Cells? 1997 ·Analytical Cellular Pathology ·Jordi Pétriz,José‐Enrique O’Connor,(unknown),Joan García‐López	11
15	Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase 1997 ·Bone Marrow Transplantation ·David Gallardo,Joan García‐López,Anna Sureda,(unknown),Christelle Ferrá,(unknown),(unknown),Salut Brunet,(unknown),(unknown),(unknown),B Amill,Rodrigo Martino,Carmen Martı́nez,(unknown),A Domingo-Albós,A Grañena	30
16	Flow cytometric analysis of P-glycoprotein function using rhodamine 123 1997 ·Leukemia ·Jordi Pétriz,Joan García‐López	74
17	CD34+ Cell Positive Selection from Mobilized Peripheral Blood by an Indirect Immunomagnetic Method: Effect of the Type of Mobilization and Assessment of Tumor Depletion Ability 1995 ·Journal of Hematotherapy ·José A. Cancelas,Sergio Querol,Carme Saurina,Joan Bertran,Ana Limón,B Amill,Jordi Pétriz,Joan García‐López	18
18	Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastomabreakdown → 1991 ·Blood ·RJ Berenson,Jack W. Singer,R.S. Hill,RG Andrews,Joan García‐López,(unknown),(unknown),Gary Spitzer,CD Buckner,ID Bernstein	455
19	Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma 1991 ·Blood ·RJ Berenson,Jack W. Singer,R.S. Hill,RG Andrews,Joan García‐López,(unknown),(unknown),Gary Spitzer,C. Dean Buckner,ID Bernstein	30
20	Stem cell selection--clinical experience. 1990 ·PubMed ·RJ Berenson,Bensinger Wi,Robert Hill,(unknown),Joan García‐López,(unknown),(unknown),CD Buckner,ID Bernstein,Thomas Ed	16

About Joan García‐López

Joan García‐López is a scholar working on Genetics, Hematology and Transplantation, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (10 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Hematology (510 citations), Genetics (337 citations) and Urology (86 citations). Joan García‐López has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include ID Bernstein, RJ Berenson, Jack W. Singer, RG Andrews, R.S. Hill, Gary Spitzer, CD Buckner, Jordi Pétriz, Joaquim Vives and Margarita Codinach. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact